【Taiyao】February 2026 Monthly Revenue NT$233 Million (YoY -20.5%)
NQ Score
50/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Taiyao Chemical, a major manufacturer of active pharmaceutical ingredients (APIs), announced its February 2026 monthly revenue of NT$233 million, a 20.5% year-on-year decrease. This figure reflects changes in customer order patterns and product mix. The company has long focused on areas such as cholesterol reduction and Vitamin D.
AI analysis data is not yet available.